Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Shares, par value US$0.001 per share
-
Shares outstanding
-
71,872,133
-
Total 13F shares
-
17,497,550
-
Share change
-
-1,402,793
-
Total reported value
-
$118,106,000
-
Price per share
-
$6.75
-
Number of holders
-
37
-
Value change
-
-$9,432,662
-
Number of buys
-
18
-
Number of sells
-
15
Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q2 2017
As of 30 Jun 2017,
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,497,550 shares.
The largest 10 holders included
SAIF Advisors Ltd, ORBIMED ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, GLG Partners LP, Eqis Capital Management, Inc., Invesco Ltd., WOLVERINE ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, and TWO SIGMA INVESTMENTS, LP.
This page lists
37
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.